EchoNext, trained on 700,000 paired ECG-echocardiogram records at NewYork-Presbyterian and Columbia, won FDA clearance on June 22, 2026 to flag six forms of structural heart disease from a routine ECG alone.
Mexico is piloting AI-assisted mammography reading tools in public clinics to cut the long wait between a screening mammogram and a diagnosis, Al Jazeera reported on October 3, 2026. The push comes as a shortage of radiologists and oncologists leaves many women, especially outside major cities, waiting weeks or months for results.
Bunkerhill Health has won FDA clearance for the first AI algorithm to detect and measure mitral annular calcification on routine chest CT scans ordered for unrelated reasons, such as lung cancer screening. The tool could turn millions of existing scans into opportunities to catch a heart condition linked to higher cardiovascular mortality, though cardiologists say the clinical response to a positive flag still needs to be defined.
Aidoc has secured FDA clearance for the first comprehensive AI triage system built on a single foundation model, bundling 14 acute diagnostic indications into one hospital workflow. The clearance arrives alongside a broader 2026 surge in autonomous AI diagnostic tools, raising both efficiency hopes and new safety questions.
A Stanford HAI report found that 32 data brokers now sell consumer data directly to generative AI developers under California's broker registry, while only about 9% of registered brokers fully comply with the state's Delete Act — a gap underscored by a separate $45,000 fine against a broker caught selling lists of Alzheimer's patients' personal data.
Sutter Health says an AI platform from Ferrum Health lifted its breast cancer detection rate from 4.8 to more than 6.0 per 1,000 screenings after running on over 35,000 mammograms in Q2 2025, part of a broader wave of AI mammography adoption at Mount Sinai, RadNet and other U.S. health systems.
AI voice-cloning scams that fake a family member's emergency call have exploded, with the FTC logging 250,000 complaints in a single quarter of 2026 and fraud investigators urging families to set up private safe words as the most reliable defense.
NewYork-Presbyterian has deployed an AI tool that analyzes prenatal health records to flag patients at risk for postpartum depression before delivery, aiming to catch a condition tied to up to 20 percent of postpartum deaths earlier than standard screening allows.
STAT reported in May 2026 that doctors used an AI tool called the Biomedical Data Translator to identify an existing drug, klonopin, as a potential treatment for a newborn's ultra-rare genetic disorder after genome sequencing alone left no clear treatment path.
Whoop's rollout of Blood Pressure Insights, an FDA-cleared ECG and AI-driven lab panels shows wearables pushing deeper into medical territory, even as physicians warn the wellness-versus-diagnostic line is getting blurry.